We would love to hear your thoughts about our site and services, please take our survey here.
Skeletor- they will have a stockpile from the 2 £912 million tenders back in January that were due for delivery by the end of March. It was split 5 ways between Innova, Abbot, etc. They will use up all of those before transitioning. Also Surescreen have a 2 year contract with DHSC to supply LFTs , so they've got enough for the short term. Let's just hope that soon we get thr RNS that we are the sovereign, although I don't believe we'll be able to supply all they need alone, so other companies will continue to get contracts through the DPS.
Floating with a valuation of £2bn and analysts talking about up to 7bn, from revenues of under £200mil (all covid related). They have decent tech, but no where near the potential here. Just goes to show if the test works the potential valuation is immense.
The Guardian: Oxford Nanopore to float on London Stock Exchange.
https://www.theguardian.com/business/2021/mar/30/oxford-nanopore-to-float-on-london-stock-exchange
It is way more than 50%, I was being conservative for fear of being accused of ramping. But as you clearly desire more, then my honest opinion is that it's 80-90% likely the large scale CV will mirror the smaller one.
As I thought earlier. Similar drop to yesterday as PI's panic about the news not having come yet. Exacerbated by more panic as a couple more companies announce tests that sound great on paper but in reality are no competition. The reality of an 8bn LFT tender still remains, of which we have an excellent chance of gaining a good chunk of revenue from, which will project this company into orbit, even on 'low' volumes of tests (10 million pm as stated by the CEO a couple of weeks ago). The reality is it will be higher than that. It all hinges on CV being similar to the smaller study (likelihood of which is more than 50% imo). Hold on to your shares guys and gals, it doesn't matter what the haters say, it's more likely than not by a fair margin that we are sitting on a once in a lifetime stock and we will all see significant returns from these levels.
Totally agree RNmyS. This guy appears and starts commentating on Avacta with reasonable comprehension and somehow he's 'the' man to follow. Having said that I agree with most of his analysis and it does provide a good summary, but it's pretty basic. Also I'm fairly sure it was his Dad that said he was 'the go to guy' on Avacta, lol.
I've got to admit I sold a few at 199p for a good profit and have sunk it into another share. Still holding a sizeable chunk though, just had to de risk and take profits. That is the name of the game afterall.